Zhonghua Jie He He Hu Xi Za Zhi. 2024 Aug 12;47(8):704-715. doi: 10.3760/cma.j.cn112147-20231127-00343.
Transbronchial lung cryobiopsy (TBLC) is an applicable technique that can provide a histologic diagnosis of interstitial lung disease(ILD). The general sample size of TBLC is much smaller than that of surgical lung biopsy (SLB), which raises more concerns about the procedure's diagnostic accuracy. A guiding consensus and guidelines on the pathological procedure of ILD with TBLC are required to better guide pathologists in diagnostic practice. The Respiratory Pathology Working Group of the Respiratory Physicians Branch of the Chinese Medical Doctor Association and the Thoracic Diseases Group of the Pathological Branch of the Chinese Medical Association, jointly organized by experts, have worked together to discuss and formulated the consensus. The consensus is based on literature review, clinical practice, collection of clinical issues, and discussion during a series of meetings. Experts approved the final proposed consensus with more than 70% of votes in favor (Delphi). The consensus summarized the delivery requirements, quality evaluation and artificial phenomena of TBLC specimens. It also proposed the diagnostic principles and procedures, types of ILD corresponding to major pathological changes, and major corresponding differential diagnoses of TBLC specimens. Finally, the consensus formed 14 recommendations for clinical diagnosis and multidisciplinary discussion. We suggest that the TBLC clinical manipulators should observe and measure the size of the specimen in time. The specimen size should be greater than 5 mm in diameter, and multiple pieces(3 to 5 pieces)are recommended. Pathologists should record the number of blocks of tissue submitted for examination and the volume, color, and texture of each specimen. Evaluation of the proportion of alveolar parenchyma/airway components under the microscope, analysis of the type and distribution of lesions will facilitate making diagnostic suggestions. The size of TBLC specimens is significantly smaller than SLB and may not show sufficient features of ILD or secondary changes. It is more necessary to combine the evaluation of clinical changes and lesion distribution assessed by HRCT for a comprehensive diagnosis. Common microscopic artefacts of TBLC specimen are mass of red blood cells, proteinaceous fluid and fibrin exudation. In the absence of hemosiderin cells or clinical signs of hemoptysis symptoms, the diagnosis of pulmonary hemorrhagic disease should be considered with caution. TBLC is not a suggested diagnosis when the pathological changes are mainly located in the pleural or subpleural lung tissues, ., pleuroparenchymal fibroelastosis. The principle of pathological diagnosis of ILD in TBLC is consistent with SLB, with a description of the main pathological morphological change and a tendentious pathological diagnosis; if the lesion is not fully shown, only a pathological description is given. A well-sampled TBLC specimen may show patchy fibrosis and fibroblast foci in UIP, supporting a pathological diagnosis of a probable UIP pattern. TBLC may not display sufficient features of the distribution of subpleural and peripheral lung lesions in UIP, as well as secondary lesions. TBLC specimens show diffuse inflammation and fibrosis with well-preserved lung tissue structure, which may support a pathological diagnosis of NSIP; if the distribution of lesions and lung tissue structure are difficult to evaluate, it is recommended that a pathological diagnosis of fibrotic ILD or cellular ILD be made. TBLC specimens may show pathological features of NSIP accompanied by organization, but it is difficult to accurately evaluate the proportion of organization area. In this scenario, a descriptive diagnosis of NSIP accompanied by organization is suggested. It is recommended to diagnose organizing pneumonia if only distal airway organization is present in TBLC; in addition to organization, if pathological histology is accompanied by obvious interstitial fibrosis and lung tissue remodelling, granuloma formation, obvious neutrophil infiltration or accompanied with abscess formation, obvious eosinophil infiltration, tissue necrosis, hyaline membrane formation or vasculitis, secondary OP should be considered. It is recommended to diagnose acute fibrinous and organizing pneumonia (AFOP) if lesions on TBLC show features of organizing pneumonia and fibrin balls. A diagnosis of smoking-related ILD (RB-ILD or DIP) is suggested when a good sampling of TBLC shows a significant accumulation of histocytes or smoker's macrophages in the alveolar spaces, and without specific changes sufficient for other diagnoses. If the lesions are confined to the lumen of respiratory bronchioles and the immediate peribronchiolar airspaces, RB-ILD is supported; if the distribution is diffuse, DIP should be considered. If it is difficult to determine the distribution of the lesions, it is necessary to integrate clinical and chest CT imaging findings to differentiate RB-ILD from DIP. A well-sampled TBLC specimen can display the pathological features of DAD and then also support such a pathological diagnosis. Lymphoid interstitial pneumonia (LIP) should show diffuse lymphocyte infiltration and lymphoid follicle formation in the lung interstitium in TBLC specimens. It is recommended that chest CT imaging be combined to determine whether the lesion is diffuse to differentiate from other lymphoproliferative diseases.
经支气管肺冷冻活检(TBLC)是一种可应用的技术,能够对间质性肺疾病(ILD)作出组织学诊断。TBLC的一般样本量远小于外科肺活检(SLB),这引发了人们对该检查诊断准确性的更多担忧。需要一份关于TBLC诊断ILD的病理操作指导性共识和指南,以更好地指导病理科医生的诊断实践。由中国医师协会呼吸医师分会呼吸病理学工作组和中华医学会病理学分会胸部疾病学组联合组织专家,共同讨论并制定了本共识。该共识基于文献回顾、临床实践、临床问题收集以及一系列会议期间的讨论。专家们以超过70%的赞成票通过了最终提出的共识(德尔菲法)。该共识总结了TBLC标本的送检要求、质量评估及人为现象。还提出了诊断原则和程序、主要病理改变对应的ILD类型以及TBLC标本的主要鉴别诊断。最后,该共识形成了14条关于临床诊断和多学科讨论的建议。我们建议TBLC临床操作人员应及时观察并测量标本大小。标本直径应大于5mm,建议取多块(3至5块)。病理科医生应记录送检检查的组织块数量以及每个标本的体积、颜色和质地。在显微镜下评估肺泡实质/气道成分的比例,分析病变类型和分布将有助于提出诊断建议。TBLC标本的大小明显小于SLB,可能无法显示出足够的ILD特征或继发性改变。更有必要结合HRCT评估的临床变化和病变分布进行综合诊断。TBLC标本常见的显微镜下人为现象是大量红细胞、蛋白质性液体和纤维蛋白渗出。在没有含铁血黄素细胞或咯血症状临床体征的情况下,应谨慎考虑诊断为肺出血性疾病。当病理改变主要位于胸膜或胸膜下肺组织时,如胸膜实质纤维弹性组织增生症,不建议采用TBLC进行诊断。TBLC诊断ILD的病理原则与SLB一致,需描述主要病理形态学改变并给出倾向性病理诊断;若病变未充分显示,则仅给出病理描述。取材良好的TBLC标本可能显示UIP中的斑片状纤维化和成纤维细胞灶,支持可能的UIP型病理诊断。TBLC可能无法显示UIP中胸膜下和周边肺病变的分布特征以及继发性病变。TBLC标本显示弥漫性炎症和纤维化,肺组织结构保存良好,这可能支持NSIP的病理诊断;若病变分布和肺组织结构难以评估,建议诊断为纤维化ILD或细胞性ILD。TBLC标本可能显示伴有机化的NSIP病理特征,但难以准确评估机化区域的比例。在这种情况下,建议作出伴有机化的NSIP描述性诊断。若TBLC中仅存在远端气道机化,建议诊断为机化性肺炎;除机化外,若病理组织学伴有明显的间质纤维化和肺组织重塑、肉芽肿形成、明显的中性粒细胞浸润或伴有脓肿形成、明显的嗜酸性粒细胞浸润、组织坏死、透明膜形成或血管炎,则应考虑继发性OP。若TBLC上的病变显示有机化性肺炎和纤维蛋白球的特征,建议诊断为急性纤维蛋白性和机化性肺炎(AFOP)。当取材良好的TBLC显示肺泡腔内有大量组织细胞或吸烟者巨噬细胞聚集,且无足以支持其他诊断的特异性改变时,建议诊断为吸烟相关ILD(RB-ILD或DIP)。若病变局限于呼吸性细支气管腔及其紧邻的支气管周围气腔,则支持RB-ILD;若分布弥漫,则应考虑DIP。若难以确定病变分布,有必要结合临床和胸部CT影像学表现来鉴别RB-ILD和DIP。取材良好的TBLC标本可显示DAD的病理特征,进而支持该病理诊断。淋巴细胞间质性肺炎(LIP)在TBLC标本中应显示肺间质弥漫性淋巴细胞浸润和淋巴滤泡形成。建议结合胸部CT影像学表现来确定病变是否弥漫性,以与其他淋巴增殖性疾病相鉴别。